Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
KH-903 by Chengdu Kanghong Pharmaceuticals Group for Metastatic Colorectal Cancer: Likelihood of Approval
KH-903 is under clinical development by Chengdu Kanghong Pharmaceuticals Group and currently in Phase II for Metastatic Colorectal Cancer. According...
Data Insights
Conbercept by Chengdu Kanghong Pharmaceuticals Group for Retinoblastoma: Likelihood of Approval
Conbercept is under clinical development by Chengdu Kanghong Pharmaceuticals Group and currently in Phase II for Retinoblastoma. According to GlobalData,...